The UK death toll from the pandemic would have been far higher if lockdowns weren’t introduced while the billions in taxpayers’ money spent on Covid testing was a missed opportunity to create a strong UK diagnostics sector, says Sir Chris Evans.
Addressing a meeting of Cardiff Business Club the Port Talbot-born life sciences serial investor and entrepreneur, he said the UK and the rest of the world was ill-prepared for the pandemic, but that lessons had been learned.
He told the club that he is dedicating the next phase of his career on the development of new cancer drugs through his venture Ellipses Pharma, which has a scientific advisory board of more than 120 of the world’s leading oncologists and financial backing from the royal family of Abu Dhabi.
